Visualise is an innovative consensus-driven medical education programme that was developed to deliver practical and relevant hands-on examples and discussion of decision making for disease control in the management of retinal diseases. The Visualise programme launched in 2019 and the content is ratified by expert consensus and opinion.
The aim of the Visualise programme is to:
- help up-skill healthcare professionals in order to improve effective diagnosis, management and treatment of retinal diseases including nAMD and its clinical complications
- provide access to expert opinions and discussions
- provide case studies that represent practical and relevant real-life examples of patient management strategies for disease control in retinal diseases
Please contact your local MSL if you require more information on Visualise.
Optimising our use of OCT for the management of nAMD
In this video, Professor Sadda covers the nuances concerning how imaging technologies are used in the management of nAMD patients. He touches upon the diagnostic standpoint, as well as decision making when it comes to the treatment and retreatment of patients.
Differential diagnosis in nAMD
Professor Geeta Menon discusses a variety of different patient cases and what to look for when diagnosing nAMD. She also introduces and demonstrates the Moorfields platform.
Optimising nAMD service: in-clinic and beyond
In this video, Dawn Sim discusses how to deliver nAMD services effectively, from referral through to personalised patient treatment and home care.
Importance of anatomical efficacy for disease control in nAMD
An animation summarising the impact of nAMD on patients, appropriate assessment and diagnosis, and best practice guidance for optimal patient care.
Treating beyond the eye
A short animation providing advice for healthcare professionals on how to improve practices, experiences and understanding for patients living with nAMD.
AMD, age-related macular degeneration; CNV, choroidal neovascularization, MSL, medical science liaison; nAMD, neovascular age-related macular degeneration; OCT, optical coherence tomography, wAMD, wet age-related macular degeneration.